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In a world where cannabinoids are being used more frequently as for medicinal purposes, the 
importance for research on cannabinoid biology is steadily increasing. The goal of this study was 
to gain a greater understanding of the effect cannabinoids have on developing zebrafish embryos. 
Work in this area of developmental biology could give way to an understanding of the safety of a 
human fetus during pregnancy with a mother who uses cannabis medicinal therapy. The 
CRISPR/Cas 9 system was utilized in this study to genetically edit the zebrafish embryo genome 
to remove the function of the Cannabinoid Receptor 1 (cnr1). Cnr1 is a one of the receptors that 
is a part of the endocannabinoid system, the other being cnr2, which serve as receptors for 
cannabinoid compounds and endogenous Anandamide. CRISPR/ cas 9 is an effective tool used 
to mutate genes in a way that allow for loss of function studies, which can provide information 
beyond the effects that occur in embryos that still have crn1 fully intact. With this in mind, our 
research was designed to observe behavioral differences in young cnr1 mutant fish and fish who 
have receptor when exposed to cannabinoids. This research could provide an opportunity to 
study the toxicology of mutant embryos when exposed to cannabinoid agonists and help 
determine which receptor they are targeting. This research is clinically important for future study 
and understanding the effects of cannabinoid therapy on early developmental patterning.  
  
 
